Stephen Mullennix, Chief Operating Officer at UroGen Pharma Ltd. (URGN), sold 5,608 shares at $37.30 ($209K) on 2019-02-14, disclosed to the SEC on 2019-03-07.
Open-market sale of $209k URGN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.30 | 2,804 | $105K | 50.0% |
| 2 | $37.30 | 2,804 | $105K | 50.0% |
| Total | $37.30 avg | 5,608 | $209K | 100% |
| Filing → |
| URGN | SELL | 2020-01-28 | $20K | — | Filing → |
| URGN | SELL | 2019-11-18 | $16K | — | Filing → |
| URGN | SELL | 2019-08-16 | $19K | — | Filing → |